F-group (family)
4018.1.1.1 FBPase
Ligands and drugs
916
Member domains
425
with ligand contacts (≤ 4 Å)
46.4% of members
420
with DrugDomain annotations
45.9% of members
194
with a DrugBank compound
21.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 4018.1.1.1 belongs to X-group 4018 a+b domain in carbohydrate phosphatases, which binds 9.3 ligand superclasses per 20 proteins, broader than 84% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00131 | AMP | Adenosine phosphate | 100 |
| DB04551 | FBP | beta-D-fructofuranose 1,6-bisphosphate | 30 |
| DB02778 | AHG | 2,5-Anhydroglucitol-1,6-Biphosphate | 21 |
| DB08484 | ROK | 4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE | 8 |
| DB07270 | 870 | N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE | 4 |
| DB07312 | A37 | 2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE | 4 |
| DB07321 | A74 | 2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE | 4 |
| DB02848 | PFE | {4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol | 3 |
| DB04175 | CLI | Mdl-29951 | 3 |
| DB01700 | AMZ | AICA ribonucleotide | 2 |
| DB12418 | LSA | Saccharin | 2 |
| DB01819 | PEP | Phosphoenolpyruvate | 1 |
| DB01902 | NEN | 1-Ethyl-Pyrrolidine-2,5-Dione | 1 |
| DB04493 | — | Fructose-6-phosphate | 1 |
| DB05053 | — | — | 1 |
| DB05518 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| AMP | ADENOSINE MONOPHOSPHATE | 99 |
| MGmetal | MAGNESIUM ION | 85 |
| F6P | 6-O-phosphono-beta-D-fructofuranose | 74 |
| FBP | 1,6-di-O-phosphono-beta-D-fructofuranose | 28 |
| MNmetal | MANGANESE (II) ION | 24 |
| ZNmetal | ZINC ION | 22 |
| AHG | 2,5-anhydro-1,6-di-O-phosphono-D-glucitol | 20 |
| FDP | 2,6-di-O-phosphono-beta-D-fructofuranose | 20 |
| TLmetal | THALLIUM (I) ION | 15 |
| CL | CHLORIDE ION | 9 |
| 2C1 | N-({4-bromo-6-[(methylcarbamoyl)amino]pyridin-2-yl}carbamoyl)-5-(2-methoxyethyl)-4-methylthiophene-2-sulfonamide | 8 |
| 947 | N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-2-ethyl[1,1'-biphenyl]-4-sulfonamide | 8 |
| 94S | N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-4-methoxy-3-(2-methylpropyl)benzene-1-sulfonamide | 8 |
| 94V | N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-2-chlorobenzene-1-sulfonamide | 8 |
| 94Y | N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-3,4-dichlorobenzene-1-sulfonamide | 8 |
| 95D | 2-[(3-{[(5-bromo-1,3-thiazol-2-yl)carbamoyl]sulfamoyl}-1-methyl-1H-indol-7-yl)oxy]acetamide | 8 |
| 95G | N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-4-[(3,4-dichloro-1-methyl-1H-pyrazol-5-yl)oxy]benzene-1-sulfonamide | 8 |
| 95M | N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-5-(2-methylpropyl)thiophene-2-sulfonamide | 8 |
| 95P | 4-bromo-N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-5-chlorothiophene-2-sulfonamide | 8 |
| 95S | N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-5-(2-methoxyethyl)-4-methylthiophene-2-sulfonamide | 8 |